LEADER 01154nam  2200361   450 
001 990000942230203316
010   $a0-7923-8729-5
035   $a0094223
035   $aUSA010094223
035   $a(ALEPH)000094223USA01
035   $a0094223
100   $a20020204d1998----km-y0itay0103----ba
101   $aeng
102   $aNL
105   $a||||||||001yy
200 1 $aSelective COX-2 inhibitors$epharmacology, clinical effects and therapeutic potential, proceedings of a conference held on march 20-21 1997 in Cannes, France$fedited by John Vane and Jack Botting
210   $aDordrecht$cKluwer Academic Publ.$cWilliam Harvey$dc1998
215   $aIX, 150 p$cill.$d24 cm
410   $12001
606 0 $aInibitori ciclossigenasi
676   $a615.7
702  1$aVANE,$bJohn R.
702  1$aBOTTING,$bJack H.
801  0$aIT$bsalbc$gISBD
912   $a990000942230203316
951   $a615.7 SEL$b1823 FARM$c615.7
959   $aBK
969   $aFAR
979   $aPATTY$b90$c20020204$lUSA01$h1448
979   $c20020403$lUSA01$h1737
979   $aPATRY$b90$c20040406$lUSA01$h1705
996   $aSelective COX-2 inhibitors$9973668
997   $aUNISA